Patents
More topics under "C07D - Heterocyclic compounds" (1,537,440)
C07D 201 - Preparation, separation, purification, or stabilisation of unsubstituted lactams (2,192)
C07D 203 - Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom (1,097)
C07D 205 - Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom (6,868)
C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom (40,304)
C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom (45,780)
C07D 211 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings (37,939)
C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273)
C07D 215 - Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems (27,676)
C07D 217 - Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems (11,865)
C07D 219 - Heterocyclic compounds containing acridine or hydrogenated acridine ring systems (2,120)
C07D 221 - Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups (10,931)
C07D 223 - Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom (8,732)
C07D 225 - Heterocyclic compounds containing rings of more than seven members having one nitrogen atom as the only ring hetero atom (1,649)
C07D 227 - Heterocyclic compounds containing rings having one nitrogen atom as the only ring hetero atom, according to more than one of groups (473)
C07D 229 - Heterocyclic compounds containing rings of less than five members having two nitrogen atoms as the only ring hetero atoms (515)
C07D 231 - Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings (25,550)
C07D 233 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings (34,408)
C07D 235 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings (15,325)
C07D 237 - Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings (8,468)
C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings (42,619)
C07D 241 - Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings (18,673)
C07D 243 - Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms (5,961)
C07D 245 - Heterocyclic compounds containing rings of more than seven members having two nitrogen atoms as the only ring hetero atoms (898)
C07D 247 - Heterocyclic compounds containing rings having two nitrogen atoms as the only ring hetero atoms, according to more than one of groups (239)
C07D 249 - Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms (17,749)
C07D 251 - Heterocyclic compounds containing 1,3,5-triazine rings (10,913)
C07D 253 - Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group (2,967)
C07D 255 - Heterocyclic compounds containing rings having three nitrogen atoms as the only ring hetero atoms, not provided for by groups (739)
C07D 257 - Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms (9,612)
C07D 259 - Heterocyclic compounds containing rings having more than four nitrogen atoms as the only ring hetero atoms (488)
C07D 261 - Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings (11,459)
C07D 263 - Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings (20,978)
C07D 265 - Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms (11,132)
C07D 267 - Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one oxygen atom as the only ring hetero atoms (2,022)
C07D 269 - Heterocyclic compounds containing rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms according to more than one of groups (111)
C07D 271 - Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms (7,144)
C07D 273 - Heterocyclic compounds containing rings having nitrogen and oxygen atoms as the only ring hetero atoms, not provided for by groups (2,368)
C07D 275 - Heterocyclic compounds containing 1, 2-thiazole or hydrogenated 1,2-thiazole rings (4,972)
C07D 277 - Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings (33,621)
C07D 279 - Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms (5,149)
C07D 281 - Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one sulfur atom as the only ring hetero atoms (1,924)
C07D 283 - Heterocyclic compounds containing rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms, according to more than one of groups (102)
C07D 285 - Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups (9,964)
C07D 291 - Heterocyclic compounds containing rings having nitrogen, oxygen and sulfur atoms as the only ring hetero atoms (1,087)
C07D 293 - Heterocyclic compounds containing rings having nitrogen and selenium or nitrogen and tellurium, with or without oxygen or sulfur atoms, as the ring hetero atoms (553)
C07D 295 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms (34,005)
C07D 301 - Preparation of oxiranes (10,136)
C07D 303 - Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom (12,512)
C07D 305 - Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms (5,442)
C07D 307 - Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom (47,108)
C07D 309 - Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings (12,815)
C07D 311 - Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings (24,127)
C07D 313 - Heterocyclic compounds containing rings of more than six members having one oxygen atom as the only ring hetero atom (3,580)
C07D 315 - Heterocyclic compounds containing rings having one oxygen atom as the only ring hetero atom according to more than one of groups (1,360)
C07D 317 - Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms (18,224)
C07D 319 - Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms (10,283)
C07D 321 - Heterocyclic compounds containing rings having two oxygen atoms as the only ring hetero atoms, not provided for by groups (2,079)
C07D 323 - Heterocyclic compounds containing more than two oxygen atoms as the only ring hetero atoms (1,581)
C07D 325 - Heterocyclic compounds containing rings having oxygen as the only ring hetero atom according to more than one of groups (168)
C07D 327 - Heterocyclic compounds containing rings having oxygen and sulfur atoms as the only ring hetero atoms (2,428)
C07D 329 - Heterocyclic compounds containing rings having oxygen and selenium or oxygen and tellurium atoms as the only ring hetero atoms (47)
C07D 331 - Heterocyclic compounds containing rings of less than five members, having one sulfur atom as the only ring hetero atom (456)
C07D 333 - Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom (32,883)
C07D 335 - Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom (4,725)
C07D 337 - Heterocyclic compounds containing rings of more than six members having one sulfur atom as the only ring hetero atom (875)
C07D 339 - Heterocyclic compounds containing rings having two sulfur atoms as the only ring hetero atoms (3,352)
C07D 341 - Heterocyclic compounds containing rings having three or more sulfur atoms as the only ring hetero atoms (281)
C07D 343 - Heterocyclic compounds containing rings having sulfur and selenium or sulfur and tellurium atoms as the only ring hetero atoms (52)
C07D 345 - Heterocyclic compounds containing rings having selenium or tellurium atoms as the only ring hetero atoms (419)
C07D 347 - Heterocyclic compounds containing rings having halogen atoms as ring hetero atoms (38)
C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587)
C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397)
C07D 407 - Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group (11,963)
C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226)
C07D 411 - Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms (2,465)
C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687)
C07D 415 - Heterocyclic compounds containing the thiamine skeleton (90)
C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773)
C07D 419 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms (1,431)
C07D 421 - Heterocyclic compounds containing two or more hetero rings, at least one ring having selenium, tellurium, or halogen atoms as ring hetero atoms (480)
C07D 451 - Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.02,4] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof (5,273)
C07D 453 - Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids (5,704)
C07D 455 - Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine (2,122)
C07D 457 - Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula: , e.g. lysergic acid (836)
C07D 459 - Heterocyclic compounds containing benz [g] indolo [2, 3-a] quinolizine ring systems, e.g. yohimbine; 16, 18-lactones thereof, e.g. reserpic acid lactone (97)
C07D 461 - Heterocyclic compounds containing indolo [3, 2, 1-d, e] pyrido [3, 2, 1-i, j] [1, 5]-naphthyridine ring systems, e.g. vincamine (286)
C07D 463 - Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula: , e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring (613)
C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559)
C07D 473 - Heterocyclic compounds containing purine ring systems (11,932)
C07D 475 - Heterocyclic compounds containing pteridine ring systems (2,718)
C07D 477 - Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula: , e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring (2,484)
C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272)
C07D 489 - Heterocyclic compounds containing 4ah-8, 9 c- iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: (2,334)
C07D 491 - Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or (29,726)
C07D 493 - Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system (17,376)
C07D 495 - Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms (21,336)
C07D 497 - Heterocyclic compounds containing in the condensed system at least one hetero ring having oxygen and sulfur atoms as the only ring hetero atoms (1,069)
C07D 498 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms (21,960)
C07D 499 - Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula: , e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring (3,448)
C07D 501 - Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula: , e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring (7,574)
C07D 503 - Heterocyclic compounds containing 4-oxa-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula: , e.g. oxapenicillins, clavulanic acid derivatives; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring (648)
C07D 505 - Heterocyclic compounds containing 5-oxa-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula: , e.g. oxacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring (556)
C07D 507 - Heterocyclic compounds containing a condensed beta-lactam ring system, not provided for by groups , or; Such ring systems being further condensed (161)
C07D 513 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups , or (15,120)
C07D 515 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms, not provided for in groups , or (877)
C07D 517 - Heterocyclic compounds containing in the condensed system at least one hetero ring having selenium, tellurium, or halogen atoms as ring hetero atoms (452)
C07D 519 - Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups or (11,041)
C07D 521 - Heterocyclic compounds containing unspecified hetero rings (16,203)
Patents for C07D - Heterocyclic compounds (10,420)
02/2006
02/09/2006WO2006014135A1 Novel piperidine derivatives as histamine h3 receptor ligands for treatment of depression
02/09/2006WO2006014134A1 Novel piperidine derivative for the treatment of depression
02/09/2006WO2006014133A1 Diarylmethyl piperazine derivatives, preparations thereof and uses thereof
02/09/2006US20060030610 Method of treating inflammatory diseases
02/09/2006US20060030569 Diarylmethyl piperazine derivatives, preparations thereof and uses thereof
02/09/2006CA2576112A1 Piperidine derivatives as histamine h3 receptor ligands
02/09/2006CA2576109A1 Novel piperidine derivatives as histamine h3 receptor ligands for treatment of depression
02/09/2006CA2576073A1 Novel piperidine derivative for the treatment of depression
02/08/2006EP1623980A1 Preparation of arthropodicidal oxadiazines
02/08/2006EP1622916A2 Heterocyclic cyclopentyl tetrahydroisoquinoline and tetrahydropyridopyridine modulators of chemokine receptor activity
02/08/2006EP1622914A2 New piperidinylamino-thieno 2,3-d pyrimidine compounds
02/08/2006EP1622615A2 Naphthyridine integrase inhibitors
02/08/2006EP1622569A2 Aza spiro alkane derivatives as inhibitors of metallproteases
02/08/2006CN1732165A 1-acyl-pyrrolidine derivatives for the treatment of viral infections
02/08/2006CN1732162A 1,2,4-triaminobenzenderivater nyttige for behandling AV forstyrrelser i sentralnervesystemet
02/08/2006CN1732153A Novel piperidine derivatives as modulators of chemokine receptor CCR5
02/08/2006CN1732006A 3-(3,5-dioxo-4,5-dihydro-3h-(1,2,4)triazin-2-yl)-benzamide derivatives as P2X7-inhibitors for the treatment of inflammatory diseases
02/07/2006US6995271 An intermediate to an antidiabetic compound, by reacting methyl (2-hydrocarbyl-5-methyloxazol-2-yl)acetate with sodium borohydride (NaBH4) using tetrahydrofuran as a solvent and methanol as activator; acetate becomes a 2-hydroxy ethyl group
02/07/2006US6995245 Formation of novel erythropoietin conjugates using transglutaminase
02/07/2006US6995167 Arylkylamine spirofuropyridines useful in therapy
02/07/2006US6994875 Process for obtaining a furan lipid-rich unsaponifiable material from avocado
02/07/2006CA2340202C Hydroxy pipecolate hydroxamic acid derivatives as mmp inhibitors
02/02/2006US20060025590 Novel compounds
02/01/2006EP1620429A1 Novel heterocyclic compounds useful for the treatment of inflammatory and allergic disorders: process for their preparation and pharmaceutical compositions containing them
02/01/2006EP1620419A2 Stabilized derivatives of ascorbic acid
02/01/2006EP1620406A2 1,2-diarylimidazoles useful as inhibitors of cox
02/01/2006EP1620399A1 Indolone-acetamide derivatives, processes for preparing them and their uses
02/01/2006EP1620108A2 Pyrazole-amine compounds useful as kinase inhibitors
02/01/2006EP1620101A2 Polymorphs of cabergoline
02/01/2006CN1729197A Tetracyclic 3-substituted indoles having serotonin receptor affinity
02/01/2006CN1729192A Optical resolution of (1-benzyl-4-methylpiperidin-3-yl) -methylamine and the use thereof for the preparation of pyrrolo 2,3-pyrimidine derivatives as protein kinases inhibitors
02/01/2006CN1729190A Pyridoindolone derivatives substituted in the 3-position by a phenyl, their preparation and their application in therapeutics
02/01/2006CN1239497C Intermediate product for preparing aralkyl and aryl alkylene heterocyclic lactam and imide
01/2006
01/31/2006US6992198 Method for the preparation of citalopram
01/31/2006US6992104 C7 carbonate taxane compositions
01/31/2006CA2347599C Process for the preparation of pyrimidine compounds
01/31/2006CA2239081C Novel 5-amino-3-cyano-4-ethylsulfinyl-1-phenyl-pyrazole compounds and their use as pesticides
01/31/2006CA2119261C Novel sidechain-bearing taxanes and intermediates thereof
01/26/2006WO2005056522A3 Indole compounds
01/26/2006US20060019960 Antitumoral analogs of ET-743
01/25/2006EP1618103A2 Polymorphs of aripiprazole
01/25/2006EP1618092A1 Aryl-substituted pyrazole-amide compounds useful as kinase inhibitors
01/25/2006EP1617840A2 Pyrazole-amide compounds useful as kinase inhibitors
01/25/2006CN1726216A C-6 modified indazolylpyrrolotriazines
01/25/2006CN1238353C Amino acid ester containing azole antifungal agent
01/24/2006US6989385 Pyrazole compounds useful as protein kinase inhibitors
01/24/2006CA2352392C Eletriptan hydrobromide monohydrate
01/24/2006CA2191832C Block oligomers containing 2,2,6,6-tetramethyl-4-piperidyl groups as stabilizers for organic materials
01/18/2006EP1615922A1 Azaindole derivatives, preparations thereof, uses thereof and compositions containing them
01/18/2006EP1615909A1 Piperazine derivatives and their use for the treatment of neurological and psychiatric diseases
01/18/2006EP1615905A2 Benzopyran compounds useful for treating inflammatory conditions
01/18/2006EP1615897A2 Pyrimidinone compounds as calcilytics
01/18/2006EP1615699A2 Benzoxazinyl-amidocyclopentyl-heterocyclic modulators of chemokine receptors
01/18/2006CN1723210A Fused furan compound
01/18/2006CN1723196A Fluoropyrrolidines as dipeptidyl peptidase inhibitors
01/18/2006CN1721397A Omega-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
01/18/2006CN1237060C Quinzolone derivatives as alpha IA/B adrenergic receptor antagonists
01/17/2006CA2362394C Heteroaryl-substituted quinolin-2-one derivatives useful as anticancer agents
01/12/2006WO2006004545A1 Tamoxifen response in pre-and postmenopausal breast cancer patients
01/12/2006WO2006004533A1 Compounds
01/12/2006WO2006004532A1 Novel hydantoin derivatives for the treatment of obstructive airway diseases
01/12/2006WO2006004507A2 New benzothiazole derivatives useful for treating cns disorders
01/12/2006WO2005033072A3 Heterocyclic amides and sulfonamides
01/12/2006US20060009517 Tricyclic inhibitors of poly(ADP-ribose) polymerases
01/12/2006US20060009497 Novel tetrahydropyridine derivatives as renin inhibitors
01/12/2006US20060009493 Indolinone hydrazides as c-Met inhibitors
01/12/2006US20060009464 4-(3-Phenyl-3-carbocycloylpropyl)-1-phenyl- or pyridylpiperazine derivatives: 1-(2-methoxyphenyl)-4-[3-(benzoyl)-3-(phenyl)propyl]piperazine oxalate; serotonin receptor antagonists; Alzheimer's disease
01/12/2006US20060009439 Novel physiologically active substances
01/12/2006CA2569727A1 Compounds
01/12/2006CA2569716A1 Hydantoin derivatives for the treatment of obstructive airway diseases
01/11/2006EP1614680A2 Process for preparing 2-iminopyrrolidine derivatives
01/11/2006EP1613640A2 Method for preparing 17 alpha-acetoxy-11 beta-(4-n,n-dimethylamin ophenyl)-19-norpregna-4,9-diene-3,20-dione, intermediates thereof, and methods for the preparation of such intermediates
01/11/2006EP1613606A2 Methods for preparing 2,3,5,6-substituted 3h-pyrimidin-4-ones
01/11/2006CN1720227A N-arylsulfonyl-3-aminoalkoxyindoles
01/11/2006CN1235887C Preparation method of xazolyl alcohol derivatives
01/05/2006WO2006001754A1 New derivatives of 5-aryl-1h-pyrrolo [2, 3b] pyridine-3-carboxamide or 5-aryl-1h-pyrrolo [2, 3b] pyridine-3-carboxylic acid
01/05/2006WO2006001752A1 Novel piperidine/8-azabicyclo [3.2.1] octan derivatives as moduilators of chemokine receptor ccr5
01/05/2006WO2006001751A1 Chemical compounds i
01/05/2006WO2006001750A1 Imidazole variants as modulators of gaba receptor for the treatment of gi disorders
01/05/2006WO2005028433A3 CRIPTO ANTAGONISM OF ACTIVIN AND TGF-β SIGNALING
01/05/2006WO2005000807A3 Benzodiazepine cgrp receptor antagonists
01/05/2006DE69828607T2 CHINOLIN- UND CHINOXALIN-VERBINDUNGEN DIE DEN VON BLUTPLÄTTCHEN ABSTAMMMENDEN WACHSTUMSFAKTOR UND/ODER PDGF- UND P56lck-TYROSIN-KINASE HEMMEN Quinoline and quinoxaline THE COMPOUNDS OF THE PLATELET FACTOR ABSTAMMMENDEN GROWTH AND / OR PDGF-TYROSINE KINASE AND p56 HEMMEN
01/05/2006CA2571087A1 Novel piperidine derivates as modulators of chemokine receptor ccr5
01/05/2006CA2570893A1 Novel piperidine/8-azabicyclo [3.2.1] octan derivatives as moduilators of chemokine receptor ccr5
01/05/2006CA2570619A1 Imidazole variants as modulators of gaba receptor for the treatment of gi disorders
01/04/2006EP1611115A1 Benzothiazole derivative compounds, compositions and uses
01/04/2006EP1611102A2 Using alkylmetal reagents for directed metalation of azaaromatics
01/04/2006EP1611095A2 A method of providing a steroid-sparing benefit with a cyclooxygenase-2 inhibitor and compositions therewith
01/04/2006EP1610790A2 Anticancer compounds
01/04/2006EP1610780A2 Cyclic protein tyrosine kinase inhibitors
01/04/2006EP1610614A2 Formulations for tyrosine kinase inhibitors
01/04/2006EP1294725B1 Multicyclic compounds and their use as inhibitors of parp, vegfr2 and mlk3 enzymes
01/04/2006CN1715269A Cyanopyrrolidine derivatives
01/03/2006CA2343236C 4,4-biarylpiperidine derivatives
12/2005
12/29/2005WO2005123748A1 Novel oxabispidine compounds and their use in the treatment of cardiac arrhythmias
12/29/2005WO2005123747A1 Novel oxabispidine compounds and their use in the treatment of cardiac arrhythmias
12/29/2005WO2005123741A1 Alkyl substituted indoloquinoxalines
12/29/2005WO2005007625A3 Heterocyclic amides with anti-tuberculosis activity
12/29/2005WO2004106295A3 Substituted piperodines and pyrrolidines as calcium sensing receptor modulators and method
12/29/2005WO2004026820A3 Method for assaying compounds that decrease the activity of poly(adp-ribose)-polymerase (parp)
1 ... 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 ... 105